Medicine and Dentistry
(3 Iodobenzyl)guanidine
24%
(3 Iodobenzyl)guanidine I 131
7%
Adolescence
28%
Adverse Event
10%
Body Mass Index
14%
Bone Density
12%
Cancer in Young Adults
23%
Cancer Therapy
7%
Chemotherapy
12%
Childhood Cancer
100%
Cohort Analysis
11%
Craniopharyngioma
19%
Cross Sectional Study
10%
Diabetes Insipidus
7%
Diagnosis
10%
Differentiated Thyroid Cancer
51%
Disease
13%
Endocrine Disease
16%
Fertility Preservation
19%
Ganglioglioma
6%
Ganglioneuroblastoma
28%
Growth Hormone
9%
Growth Hormone Deficiency
10%
Health Outcomes
14%
Hypothyroidism
11%
Intracranial Tumor
27%
Iodine 131
25%
Late Effect
30%
Malignant Neoplasm
18%
Multiple Endocrine Neoplasia
7%
Multiple Endocrine Neoplasia Type 2b
8%
Neck
7%
Neoplasm
22%
Odds Ratio
7%
Papillary Thyroid Cancer
7%
Pediatrics
30%
Potassium Iodide
7%
Prevalence
24%
Primary Ovarian Insufficiency
9%
Quality of Life
13%
Radiation Therapy
22%
Radioactive Iodine
9%
Systematic Review
23%
Thyroid Cancer
16%
Thyroid Disease
17%
Thyroid Function
10%
Thyroid Gland
24%
Thyroid Medullary Carcinoma
8%
Thyrotropin
12%
Thyroxine
16%
Keyphrases
123I-MIBG
9%
131I-metaiodobenzylguanidine
16%
131I-MIBG
8%
Adult Cancer
18%
Adult Survivors
11%
Body Mass Index
10%
Bone Mineral Density
8%
Brain Tumor
8%
Cancer Guidelines
18%
Chemotherapy
10%
Childhood Brain Tumor Survivors
15%
Childhood Cancer
35%
Childhood Cancer Survivor Study
8%
Childhood Cancer Survivors
65%
Childhood-onset
8%
Congenital Hypothyroidism
9%
Craniopharyngioma
22%
Differentiated Thyroid Cancer
15%
Differentiated Thyroid Carcinoma
31%
Dutch
29%
Endocrine Disorders
16%
Fertility Preservation
14%
Free Thyroxine
8%
Growth Hormone Treatment
8%
Health Outcomes
9%
Hypothalamic Obesity
23%
Hypothalamic-pituitary Axis
19%
Hypothalamic-pituitary Dysfunction
13%
Late Effects
24%
Long-term Survivors
13%
Multiple Endocrine Neoplasia Type 2 (MEN2)
11%
Netherlands
10%
Neuroblastoma
28%
Pediatric Craniopharyngioma
8%
Pediatric Thyroid Carcinoma
22%
Pituitary Dysfunction
11%
Potassium Iodide
8%
Prevalence Risk
8%
Quality of Life
8%
Quality of Survival
9%
Radiotherapy
15%
Risk Factors
27%
Survivors
57%
Thyroid Cancer
12%
Thyroid Dysfunction
18%
Thyroid Function
10%
Thyroid Gland
16%
Thyroid Hormones
10%
Thyroxine
10%
Working Diagnosis
15%